Cargando…
GeneChip expression profiling identified OLFML2A as a potential therapeutic target in TNBC cells
BACKGROUND: An elevated level of olfactomedin-like-2A (OLFML2A) is unfavorable for female breast cancer patients. Patients with a high mRNA level of OLFML2A receive a poor prognosis. Therefore, we speculate that inhibiting the expression of this gene may be beneficial to breast cancer patients. We p...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011253/ https://www.ncbi.nlm.nih.gov/pubmed/35433966 http://dx.doi.org/10.21037/atm-22-757 |